Development of tiotropium inhalation formulations for the treatment of chronic obstructive pulmonary disease
- Authors
- Oh, N.M.; Oh, K.T.; Youn, Y.S.; Lee, D.-K.; Cha, K.-H.; Lee, E.S.
- Issue Date
- Feb-2013
- Publisher
- Kluwer Academic Publishers
- Keywords
- Chronic obstructive pulmonary disease; Inhalant formulation; PLGA; Tiotropium
- Citation
- Journal of Pharmaceutical Investigation, v.43, no.1, pp 71 - 74
- Pages
- 4
- Journal Title
- Journal of Pharmaceutical Investigation
- Volume
- 43
- Number
- 1
- Start Page
- 71
- End Page
- 74
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/19849
- DOI
- 10.1007/s40005-013-0054-7
- ISSN
- 2093-5552
2093-6214
- Abstract
- Tiotropium, a longer acting anticholinergic bronchodilator, has been widely used for treatment of chronic obstructive pulmonary disease (COPD). To improve the therapeutic effect of tiotropium, we developed various inhalation microparticular formulations of tiotropium using starch, hyaluronate, bovine serum albumin (BSA), and poly(lactide-co-glycolide) (PLGA). All formulations showed ~90 % inhalation efficiency in the lung epithelium of BALB/c mice after initial administration. Interestingly, when compared to other formulations using starch, hyaluronate, and BSA, the inhalation formulation of tiotropium using PLGA showed longer drug residence (up to 7 days) in in vivo lung epithelium. We believe that this microparticle system is expected to improve the treatment efficacy for the patients with COPD by maintaining drug therapeutic effect during the extended period after initial inhalation. © 2013 The Korean Society of Pharmaceutical Sciences and Technology.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/19849)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.